SSU72P8: A Potential Drug Target and Biomarker (G136157)

Target Name: SSU72P8

NCBI ID: G136157

Other Name(s): SSU72 pseudogene 8

SSU72P8: A Potential Drug Target and Biomarker

Introduction

SSU72P8, also known as SSU72 pseudogene 8, is a non-coding RNA molecule that has been identified in various tissues and cell types. Its function and biological significance are still being explored, but research has shown that it plays an important role in the regulation of gene expression and has potential as a drug target or biomarker.

History of SSU72P8

The discovery of SSU72P8 was made using a computational approach, where researchers identified a unique RNA molecule that was highly expressed in various tissues and cell types, but was not found in the human genome database. Further analysis revealed that the RNA molecule had a high degree of sequence identity to known non-coding RNAs, including microRNAs and small nucleotide non-coding RNAs (snRNAs).

Function and mechanism of SSU72P8

Function

SSU72P8 has been shown to play a role in the regulation of gene expression by binding to specific target genes. This interaction between SSU72P8 and target genes suggests that SSU72P8 may function as a negative regulator, specifically a RNA-protein interaction (RNA-PKM) regulator.

Additionally, SSU72P8 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and cell cycle progression. It has been shown to be involved in the regulation of cell cycle-related genes, including the G1 phase and the G2/M phase, as well as the regulation of cell apoptosis.

Mechanism

The mechanism of how SSU72P8 interacts with its target genes is not yet fully understood, but it is thought to involve a process called RNA-protein interaction (RNA-PKM). RNA-PKM is a process where RNA molecules interact with proteins to regulate their activity, often by binding to specific protein targets.

One of the key components of RNA-PKM is the RNA-protein interaction, which involves the formation of a complex between the RNA molecule and its protein partner. This interaction is usually reversible, and the stability of the interaction is regulated by various factors, including the presence of bound protein inhibitors or activators.

Based on these mechanisms, it is thought that SSU72P8 may function as a negative regulator by binding to specific target genes and regulating their activity. This regulation can lead to the expression of target genes and the inhibition of their activity, ultimately leading to the regulation of cellular processes such as cell growth, apoptosis, and cell cycle progression.

Potential as a drug target

The potential drug target for SSU72P8 is an area of 鈥嬧?媜ngoing research, and its potential as a drug target is based on its function as a negative regulator. Studies have shown that SSU72P8 can interact with various drug targets and have been identified as potential drug targets for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

For example, SSU72P8 has been shown to interact with the target gene PDGF-BB, which is a key regulator of cell growth and has been implicated in various diseases, including cancer. Studies have shown that the interaction between SSU72P8 and PDGF-BB can lead to the regulation of cellular processes, including cell growth, apoptosis, and cell cycle progression.

Another potential drug target for SSU72P8 is the protein p53, which is a well-known regulator of DNA damage repair and has been implicated in various diseases, including cancer. Studies have shown that the interaction between SSU72P8 and

Protein Name: SSU72 Pseudogene 8

More Common Targets